No abstract available
MeSH terms
-
Chemotherapy, Adjuvant
-
Combined Modality Therapy
-
Dose-Response Relationship, Drug
-
Humans
-
Interferon alpha-2
-
Interferon-alpha / administration & dosage*
-
Melanoma / mortality
-
Melanoma / pathology
-
Melanoma / therapy*
-
Multicenter Studies as Topic
-
Neoplasm Staging
-
Prospective Studies
-
Randomized Controlled Trials as Topic
-
Recombinant Proteins
-
Skin Neoplasms / mortality
-
Skin Neoplasms / pathology
-
Skin Neoplasms / therapy*
-
Survival Rate
Substances
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins